Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-11-005153
Filing Date
2011-08-05
Accepted
2011-08-05 16:40:30
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 c66462_10-q.htm 10-Q 407292
2 c66462_ex10-8.htm EX-10.8 27357
3 c66462_ex31-1.htm EX-31.1 7551
4 c66462_ex31-2.htm EX-31.2 7543
5 c66462_ex32-1.htm EX-32.1 3296
6 c66462_ex32-2.htm EX-32.2 3305
  Complete submission text file 0000930413-11-005153.txt   2435651

Data Files

Seq Description Document Type Size
7 enzn-20110630.xml EX-101.INS 398060
8 enzn-20110630.xsd EX-101.SCH 17948
9 enzn-20110630_cal.xml EX-101.CAL 28674
10 enzn-20110630_def.xml EX-101.DEF 85431
11 enzn-20110630_lab.xml EX-101.LAB 122878
12 enzn-20110630_pre.xml EX-101.PRE 98263
Mailing Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854
Business Address 20 KINGSBRIDGE ROAD ATT: GENERAL COUNSEL PISCATAWAY NJ 08854 732-980-4500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12957 | Film No.: 111014711
SIC: 2836 Biological Products, (No Diagnostic Substances)